Comprehensive Evaluation of Plasma 7-Ketocholesterol and Cholestan-3β,5α,6β-Triol in an Italian Cohort of Patients Affected by Niemann-Pick Disease due to NPC1 and SMPD1 Mutations

Autor: Andrea Dardis, Agata Fiumara, Stefania Zampieri, Francesco Brancati, Milena Romanello, Annalisa Sechi, Rossella Parini, Laura Deroma, Bruno Bembi, Barbara Borroni, Amalia C. Bruni, Nadia Bortolotti, Cinzia Valeria Russo, Andrea Bordugo
Přispěvatelé: Romanello, M., Zampieri, S., Bortolotti, N., Deroma, L., Sechi, A., Fiumara, A., Parini, R., Borroni, B., Brancati, F., Bruni, A., Russo, C. V., Bordugo, A., Bembi, B., Dardis, A.
Jazyk: angličtina
Rok vydání: 2016
Předmět:
0301 basic medicine
Oncology
medicine.medical_specialty
Clinical Biochemistry
Hepatosplenomegaly
Liquid chromatography-tandem-mass spectrometry
Niemann-Pick
Oxysterols
Variant biochemical phenotype
Calibration
Carrier Proteins
Cholestanes
Cohort Studies
Humans
Italy
Ketocholesterols
Membrane Glycoproteins
Niemann-Pick Diseases
Reproducibility of Results
Sphingomyelin Phosphodiesterase
Mutation
Biochemistry
Biochemistry (medical)
Context (language use)
Disease
Liquid chromatography-tandem–mass spectrometry
03 medical and health sciences
Oxysterol
0302 clinical medicine
Oxysterols Niemann-Pick
Niemann-Pick C1 Protein
Internal medicine
medicine
Chemistry
Intracellular Signaling Peptides and Proteins
General Medicine
medicine.disease
Phenotype
030104 developmental biology
Immunology
Cohort
lipids (amino acids
peptides
and proteins)

Differential diagnosis
medicine.symptom
NPC1
Niemann–Pick disease
030217 neurology & neurosurgery
Popis: Niemann-Pick C disease (NPCD) is a rare autosomal recessive neurovisceral disorder with a heterogeneous clinical presentation. Cholestan-3β,5α,6β-triol and 7-ketocholesterol have been proposed as biomarkers for the screening of NPCD. In this work, we assessed oxysterols levels in a cohort of Italian patients affected by NPCD and analyzed the obtained results in the context of the clinical, biochemical and molecular data. In addition, a group of patients affected by Niemann-Pick B disease (NPBD) were also analyzed. NPC patients presented levels of both oxysterols way above the cut off value, except for 5 siblings presenting the variant biochemical phenotype who displayed levels of 3β,5α,6β-triol below or just above the cut-off value; 2 of them presented also normal levels of 7-KC. Both oxysterols were extremely high in a patient presenting the neonatal systemic lethal phenotype. All NPB patients showed increased oxysterols levels. In conclusion, the reported LC-MS/MS assay provides a robust non-invasive screening tool for NPCD. However, false negative results can be obtained in patients expressing the variant biochemical phenotype. These data strengthen the concept that the results should always be interpreted in the context of the patients' clinical picture and filipin staining and/or genetic studies might still be undertaken in patients with normal levels of oxysterols if symptoms are highly suggestive of NPCD. Both oxysterols are significantly elevated in NPB patients; thus a differential diagnosis should always be performed in patients presenting isolated hepatosplenomegaly, a common clinical sign of both NPCD and NPBD.
Databáze: OpenAIRE